Sydnexis
Drug DiscoveryWebsite
Developer of a eyecare medicine and drug designed to treat myopia. The company offers a topical eyedrop formulation used to treat the progression of myopia in children, enabling medical professionals ...
Valuation
$0
Share Price
N/A
Total Raised
$76.5M
Last Round
Later Stage VC (Series B)
Aug 2021
Latest Funding Round
Later Stage VC (Series B)
Aug 10, 2021
$50M
raised
Investors
+6 other investors